10.07.2014 • News

Centroflora Buys Boehringer Phytochemical API Portfolio

Centroflora CMS (C2 Pharma), a specialist in active pharmaceutical ingredients (APIs), has acquired manufacturing assets for a group of phytochemical APIs from German drugmaker Boehringer Ingelheim.

The Brazilian company also has signed a multi-year exclusive agreement with Boehringer to supply the market with phytochemical APIs. The acquired portfolio includes atropine and atropine sulfate, digoxin and digoxin micron, along with metildigoxin, homatropine methylbromide, homatropine hydrobromide and dihydroergotamine mesylate

Centroflora CMS will also distribute its own pilocarpine APIs, including pilocarpine hydrochloride and pilocarpine Nitrate, to more than 100 pharmaceutical companies in the US, Europe, South America, Asia, Africa and Australia.

Andrew Badrot, CEO of Centroflor, said the company plans to Immediately provide "a well-defined roadmap for the continuous supply ofphytochemical APIs to the marketplace."

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

March 24, 2026 | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

Top-Feature

most read